Clinical Study
Retrospective Case Reports of Anemic Pregnant Women Receiving Intravenous Ferric Carboxymaltose: Experience from a Tertiary Hospital in Spain
Table 1
Response to intravenous ferric carboxymaltose.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Data shown as median (IQR) or (%). Three women received at least one further treatment (two women received two FCM administrations and one woman received three FCM administrations). †One woman received two FCM administrations of 1000 mg iron three weeks apart. #Routine laboratory control was performed either between 7 and 14 days (women in third trimester of pregnancy) or between 20 and 40 days (women in first or second trimester of pregnancy) after treatment. FCM, ferric carboxymaltose; Hb, hemoglobin; IQR, interquartile range. |